Noxopharm Limited (ASX:NOX) has applied for quotation of 1,240,351 ordinary fully paid shares issued to Non-Executive Directors in lieu of directors' fees accrued up to 30 June 2026, with the issue taking place on 20 November 2026 at a consideration of $0.0907 per share.
Key Points
- 1,240,351 ordinary fully paid shares issued and applied for quotation on 20 November 2026
- Shares issued in lieu of Non-Executive Directors' fees accrued up to 30 June 2026, as approved by shareholders at the 2026 Annual General Meeting held on 17 November 2026
- Issue price of $0.0907 per share, based on the 10-trading day volume weighted average price up to and including 30 June 2026
- Total quoted ordinary fully paid shares on issue following quotation: 335,331,853
Share Issue Terms and Shareholder Approval
According to the filing, the 1,240,351 ordinary fully paid shares were issued as part of a placement or other type of issue, as previously notified to ASX in an Appendix 3B dated 19 November 2026. Shareholders approved the issue of shares to Non-Executive Directors in lieu of fees at the 2026 Noxopharm Annual General Meeting, held on 17 November 2026. The filing states that no further issues of securities are yet to take place to complete the transaction referred to in the Appendix 3B.
Issue Price Calculation and Consideration
The filing discloses that the consideration per security is estimated at $0.0907 (AUD). The issue price was determined based on the 10-trading day volume weighted average price of Noxopharm shares traded on the ASX up to and including 30 June 2026. The shares were not issued for a cash consideration, with the company disclosing that the securities were provided in lieu of directors' fees accrued up to 30 June 2026 by Non-Executive Directors of the company.
Issued Capital Following Quotation
Following the quotation of the new securities, the total number of Noxopharm ordinary fully paid shares on issue is recorded in the filing as 335,331,853. The company's unquoted securities comprise 1,290,000 options expiring 10 September 2027 with an exercise price of $0.1488, listed under the code NOXAI, and 3,850,000 convertible notes listed under the code NOXAH, according to the filing. The filing notes that these automatically generated figures may not reflect the entity's current issued capital if other forms are currently with ASX for processing.





Please wait processing your request...